Zobrazeno 1 - 10
of 177
pro vyhledávání: '"P.G. Vlachoyiannopoulos"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Clinical Practice ISBN: 9783030537357
Sjogren’s syndrome (Ss) is a systemic autoimmune disorder which is characterized mainly by local involvement of exocrine glands leading to xerostomia and xerophtalmia, parotid and minor salivary gland gland enlargement and dysfunction of all exocri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b9ac2efc15d9416907cf48e5b2633e4
https://doi.org/10.1007/978-3-030-53736-4_23
https://doi.org/10.1007/978-3-030-53736-4_23
Autor:
Marinos C. Dalakas, P.G. Vlachoyiannopoulos, Dimitris Pikazis, Athanasios G. Tzioufas, Michalis L. Kosmidis
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
ObjectiveTo assess whether canakinumab, a monoclonal antibody against IL-1β approved for autoinflammatory diseases, is effective as target-specific therapy in patients with sporadic inclusion body myositis (sIBM).MethodsBecause in sIBM IL-1β coloca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c5227ec5085f8be1d8804a8239196d
https://pubmed.ncbi.nlm.nih.gov/31355317
https://pubmed.ncbi.nlm.nih.gov/31355317
Autor:
Anastasia Kotanidou, P.G. Vlachoyiannopoulos, Marinos C. Dalakas, L. Chatzis, H. Alexopoulos, Edison Jahaj, A. G. Tzioufas, Eleni Magira, K. Bitzogli
Publikováno v:
Annals of the Rheumatic Diseases. 80:1381.2-1381
Background:We1 and others2 have previously shown that ICU admitted patients with COVID-19 developed high titers of anti-SARS-CoV-2 antibodies, but also autoantibodies, some of which are pathogenic. We re-evaluated 8 patients of those survived after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbd3dcb0e180bdc0fc986e94f304e0ef
https://doi.org/10.1136/annrheumdis-2021-eular.3554
https://doi.org/10.1136/annrheumdis-2021-eular.3554
Autor:
A. G. Tzioufas, A. Tsirogianni, P.G. Vlachoyiannopoulos, G. Boutzios, Efstathia K. Kapsogeorgou, C. Sfontouris, Ourania D Argyropoulou
Publikováno v:
Annals of the Rheumatic Diseases. 80:668.1-668
Background:The clinical significance of pANCA by indirect immunofluorescence is well-established. However, their clinical utility is sometimes hindered by the fact that pANCA are also detected in various autoimmune diseases. Myeloperoxidase (MPO) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc92216e5d813b6cdd2b4a64e4f782fb
https://doi.org/10.1136/annrheumdis-2021-eular.1949
https://doi.org/10.1136/annrheumdis-2021-eular.1949
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Evangelos J. Giamarellos-Bourboulis, E. Theotikos, Athanassios Karageorgos, P.G. Vlachoyiannopoulos, Panagiotis Koufargyris, N. Solomonidi, A. Elezoglou
Publikováno v:
Annals of the Rheumatic Diseases. 79:1384.2-1385
Background:The function of platelets (PLT), which can serve as reservoirs of transforming growth beta, leads to the question whether they are activated in systemic sclerosis (SSc) to such an extent as to associate with clinical severity.Objectives:To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3d9ddae1fca1053c205796f12b38cfd
https://doi.org/10.1136/annrheumdis-2020-eular.5278
https://doi.org/10.1136/annrheumdis-2020-eular.5278
Autor:
P.G. Vlachoyiannopoulos, A. G. Tzioufas, EN Mole, A. Tarassi, T. Athanassiades, Menelaos N. Manoussakis, A. Tsirogianni, V. Kitsiou, S. Gazi
Publikováno v:
Annals of the Rheumatic Diseases. 79:1404-1404
Background:Genetic and environmental factors interact in aetiopathogenesis of Rheumatoid Arthritis (RA). However, it remains unclear whether current smoking, presence of Rheumatoid factor (RF) and HLA-DRB1 SE influence the radiographic outcome.Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2998be3fa3af1259249ae6fc1ba28f80
https://doi.org/10.1136/annrheumdis-2020-eular.4931
https://doi.org/10.1136/annrheumdis-2020-eular.4931
Autor:
D. Dimopoulou, S.-N. Liossis, I. Kallitsakis, Theodoros Dimitroulas, P.G. Vlachoyiannopoulos, Charalampos Papagoras, Panagiotis Athanassiou, A. Georgiadis, Maria G Tektonidou, T. Sarikoudis, D. Soukera, P. Tsatsani, P.P. Sfikakis, C. Gerodimos, Prodromos Sidiropoulos, E. Theodorou, E. Tsiakou, D. Karamitsos, G. Gkoni, Dimitrios Pikazis, G. Vosvotekas, Dimitrios Vassilopoulos, Clio P. Mavragani, M. Zakalka, Christina G. Katsiari, L. Settas, I. Raftakis, D. Daoussis, C. Iliou, Katerina Laskari, Paraskevi V. Voulgari
Publikováno v:
Annals of the Rheumatic Diseases. 79:845.1-845
Background:Interleukin-1 (IL-1) is a major mediator of the inflammatory cascade in Still’s disease and an established therapeutic target.Objectives:To assess the efficacy and safety of the IL-1b inhibitor canakinumab in adolescent and adult patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3f3c2563f7c8b992338c26f58e226df
https://doi.org/10.1136/annrheumdis-2020-eular.5217
https://doi.org/10.1136/annrheumdis-2020-eular.5217
Autor:
P.P. Sfikakis, Pelagia Katsimbri, Konstantina Karagianni, Maria G Tektonidou, Alexandros A. Drosos, P. Vounotrypidis, L. Pantazi, Kalliopi Fragkiadaki, C. Georganas, Alexandros Garyfallos, Alexios Iliopoulos, Lazaros I. Sakkas, Dimitrios Vassilopoulos, P.G. Vlachoyiannopoulos, P. Tsatsani, Eleftheria P. Grika, Dimitrios T. Boumpas, Argyro Lazarini, Evripidis Kaltsonoudis, S. Gazi, Theodoros Dimitroulas, M. Areti, George D. Kitas, Konstantinos Thomas, Panagiotis Georgiou, Kyriaki A. Boki, Konstantinos Melissaropoulos, Gerasimos Evangelatos
Publikováno v:
Rheumatoid arthritis – biological DMARDs.
Background A number of cross-sectional studies have shown that approximately one quarter of rheumatoid arthritis (RA) patients are being treated with biologic disease modifying anti-rheumatic drugs (bDMARDs) as monotherapy. Data regarding the retenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d55f2d49dfd8d532ea873d80233106c
https://doi.org/10.1136/annrheumdis-2018-eular.5780
https://doi.org/10.1136/annrheumdis-2018-eular.5780